Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands; Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Department of Cardiovascular Surgery, Gülhane School of Medicine, University of Health Sciences, Ankara, Turkey.
J Vasc Surg Venous Lymphat Disord. 2018 May;6(3):321-329. doi: 10.1016/j.jvsv.2017.09.013. Epub 2018 Feb 13.
Minimally invasive interventions by recanalization, percutaneous transluminal angioplasty, and stenting in post-thrombotic syndrome (PTS) obstructions and iliac vein compression syndrome (IVCS) have shown good results. Until recently, no dedicated venous stents were available, and stent-related issues accounted for a decrease in patency scores. The introduction of dedicated stents with more flexibility and higher radial forces could result in higher patency scores. This study focused on the outcomes of patients treated by a dedicated sinus-Venous stent (OptiMed GmbH, Ettlingen, Germany). Patency rates and clinical evaluation are described for both PTS and IVCS patients.
A total of 200 patients treated at a tertiary university referral center were analyzed. A percutaneous procedure was performed in 103 (51%) PTS patients and 48 (24%) IVCS patients. In 49 (25%) patients, a hybrid procedure was executed. Patency rates and complications were analyzed by duplex ultrasound. Clinical improvement was scored by Venous Clinical Severity Score, Villalta scale, and venous claudication rates.
The mean age was 43.2 ± 14.5 (17-81) years, and 66% were female. Mean Villalta score decreased from 10.5 ± 4.2 (3-24) to 5.3 ± 3.8 (0-14) at the latest follow-up (P < .001). Venous Clinical Severity Score decreased by a total of 3 points (P < .001). At baseline, venous claudication was present in 132 patients, which subsided in 115 (87%). Overall patency scores revealed a primary patency of 68%, assisted primary patency of 83%, and secondary patency of 90% with a median follow-up of 12 (11-12) months. Of all included patients, 122 (61%) did not have a complication during follow-up; the most frequent complications were in-stent restenosis (n = 23) and occlusion (n = 25) of the stented tract.
Short-term clinical results using the sinus-Venous stent are comparable to previous research. Loss of stent patency due to stent-related issues like kinking or tapering is hardly ever seen in this short-term follow-up.
经腔内再通、经皮腔内血管成形术和支架置入术治疗血栓后综合征(PTS)阻塞和髂静脉压迫综合征(IVCS)已显示出良好的效果。直到最近,还没有专门用于静脉的支架,而与支架相关的问题导致了通畅评分的下降。具有更高柔韧性和更高径向力的专用支架的引入可能会导致更高的通畅评分。本研究专注于使用专用窦内静脉支架(德国埃特林根 OptiMed GmbH)治疗的患者的结果。描述了 PTS 和 IVCS 患者的通畅率和临床评估结果。
对一家三级大学转诊中心治疗的 200 名患者进行了分析。103 名(51%)PTS 患者和 48 名(24%)IVCS 患者进行了经皮手术。49 名(25%)患者接受了混合手术。通过双功能超声分析通畅率和并发症。临床改善情况通过静脉临床严重程度评分、Villalta 评分和静脉跛行率进行评分。
平均年龄为 43.2±14.5(17-81)岁,66%为女性。平均 Villalta 评分从 10.5±4.2(3-24)降至末次随访时的 5.3±3.8(0-14)(P<.001)。静脉临床严重程度评分总共降低了 3 分(P<.001)。基线时,132 名患者存在静脉跛行,其中 115 名(87%)缓解。总体通畅评分显示,原发性通畅率为 68%,辅助原发性通畅率为 83%,继发性通畅率为 90%,中位随访时间为 12(11-12)个月。所有纳入患者中,122 名(61%)在随访期间无并发症;最常见的并发症是支架内再狭窄(n=23)和支架内狭窄(n=25)。
使用窦内静脉支架的短期临床结果与既往研究相当。在这种短期随访中,很少因支架相关问题(如支架扭曲或变细)导致支架通畅丧失。